The living well with dementia pilot randomised controlled trial

Not Applicable

Completed

• Conditions: Topic: Dementias and Neurodegenerative Diseases Research Network; Subtopic: Dementia; Disease: Dementia; Mental and Behavioural Disorders; Unspecified dementia

• Registration Number: ISRCTN25079950
• Lead Sponsor: Southern Health NHS Foundation Trust (UK)

Brief Summary

2015 results in https://www.ncbi.nlm.nih.gov/pubmed/25196239

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-01-17
• Study Completion: 2013-12-31
• Last Update Posted: 30 July 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

1. A diagnosis made by a Consultant Psychiatrist of either probable Alzheimer?s disease according to the NINCDS-ADRDA criteria (National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association) (McKhann et al. 1984) or probable Vascular Dementia according to the NINDS-AIREN criteria (National Institute of Neurological Disorders and Stroke - Association Internationale pour la Recherche et l'Enseignement en Neurosciences) (Roman et al. 1993) within the previous 6 months of entry to the study.
2. Male & Female; Upper Age Limit 100 years ; Lower Age Limit 50 years
3. Acknowledge, at least occasionally, that they have a memory problem
4. Be willing to attend a group program
5. Have adequate communication skills to enable group participation
6. Have a MMSE (Mini-Mental State Examination; Folstein, Folstein & McHugh, 1975) score of at least 18

Exclusion Criteria

1. Participants will be excluded from the study if they have a significant pre-morbid history of functional mental health problems (e.g. psychosis)
2. Participants will be excluded from the study if they have taken part in similar research or dementia group projects in the past

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of Life in Alzheimer?s disease scale (QOL-AD; Logsdon et al. 1999). The QOL-AD is a brief, 13-item measure designed specifically to obtain a rating of the participant's Quality of Life. It was developed for individuals with dementia, based on input from the person, their family and from experts in the field, to maximize construct validity, and to ensure that the measure focuses on quality of life domains thought to be important in cognitively impaired older adults. It uses simple and straightforward language and responses & includes assessments of the individual's relationships with friends and family, concerns about finances, physical condition, mood, and an overall assessment of life quality.